Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Darusentan

SKU: orb1220947

Description

Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries.(In Vitro):Darusentan ((S)-Darusentan) competes for radiolabeled endothelin binding in rat aortic vascular smooth muscle cells (RAVSMs) membranes with single-site kinetics, exhibiting a Ki=13 nM. In isolated endothelium-denuded rat aortic rings, Darusentan inhibits endothelin-induced vascular contractility with a pA2=8.1±0.14. Darusentan ( 0.001-1μM) inhibits ET-1-induced signaling in cultured RAVSMs.(In Vivo):Darusentan (30 mg/kg per day orally for weeks 3 and 4) reverses aortic alterations produced by infusion of Norepinephrine (2.5 μg/kg per min subcutaneously for 2 and 4 weeks) in male Sprague Dawley rats.

Images & Validation

Key Properties

CAS Number171714-84-4
MW410.43
Purity>98% (HPLC)
FormulaC22H22N2O6
SMILESCOc1cc(OC)nc(O[C@H](C(O)=O)C(OC)(c2ccccc2)c2ccccc2)n1
TargetEndogenous Metabolite
SolubilityDMSO:125 mg/mL (304.57 mM);Water:Insoluble

Bioactivity

In Vivo
Darusentan (30 mg/kg per day orally for weeks 3 and 4) reverses aortic alterations produced by infusion of Norepinephrine (2.5 μg/kg per min subcutaneously for 2 and 4 weeks) in male Sprague Dawley rats. Animal model: Twenty-four (eight per group) male Sprague Dawley rats weighing 175±200 g. Dosage: 30 mg/kg. Administration: Administered orally in rat food for weeks 3 and 4. Result: Reversed aortic alterations produced by infusion of Norepinephrine (2.5 μg/kg).
In Vitro
Darusentan ((S)-Darusentan) competes for radiolabeled endothelin binding in rat aortic vascular smooth muscle cells (RAVSMs) membranes with single-site kinetics, exhibiting a Ki=13 nM. In isolated endothelium-denuded rat aortic rings, Darusentan inhibits endothelin-induced vascular contractility with a pA2=8.1±0.14. Darusentan ( 0.001-1 μM) inhibits ET-1-induced signaling in cultured RAVSMs.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Lu-135252

Similar Products

  • Darusentan [orb1301774]

    98.72% (May vary between batches)

    171714-84-4

    410.43

    C22H22N2O6

    200 mg, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg, 25 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 120.00
5 mg
$ 180.00
10 mg
$ 290.00
25 mg
$ 510.00
50 mg
$ 830.00
100 mg
$ 1,190.00